Department of Public Health and Welfare, Finnish Institute for Health and Welfare, Helsinki, Finland.
Health Informatics Institute, Morsani College of Medicine, University of South Florida, Tampa, FL, United States.
J Nutr. 2024 Aug;154(8):2493-2500. doi: 10.1016/j.tjnut.2024.06.005. Epub 2024 Jun 19.
The Trial to Reduce IDDM in the Genetically at Risk (TRIGR) (NCT00179777) found no difference type 1 diabetes risk between hydrolyzed and regular infant formula. However, cow milk consumption during childhood is consistently linked to type 1 diabetes risk in prospective cohort studies.
Our primary aim was to study whether humoral immune responses to cow milk and cow milk consumption are associated with type 1 diabetes in TRIGR children.
TRIGR comprised 2159 children with genetic susceptibility to type 1 diabetes born between 2002 and 2007 in 15 countries. Children were randomly assigned into groups receiving extensively hydrolyzed casein or a regular cow milk formula and followed up until age 10 y. Type 1 diabetes-related autoantibodies and antibodies to cow milk proteins were analyzed. Infant formula intake was measured by structured dietary interviews and milk consumption with a food frequency questionnaire. Associations of milk antibodies and milk consumption with risk to develop type 1 diabetes were analyzed using Cox survival model.
Cow milk antibody concentrations both in cord blood [hazards ratio (HR) for islet autoimmunity: 1.30; 95% CI: 1.05, 1.61; HR for type 1 diabetes: 1.32; 95% CI: 1.02, 1.71] and longitudinally from birth to 3 years (HR for islet autoimmunity: 1.39; 95% CI: 1.07, 1.81; HR for type 1 diabetes: 1.43; 95% CI: 1.04, 1.96) were associated with increased risk of developing type 1 diabetes. The amount of regular infant formula was associated with reduced islet autoimmunity risk in the regular infant formula group (HR: 0.92; 95% CI: 0.85, 0.99). Furthermore, frequent liquid milk consumption after infancy was associated with increased risk of islet autoimmunity or type 1 diabetes.
Elevated cow milk antibody concentrations and high consumption of liquid milk after infancy are related to type 1 diabetes development in children with an increased genetic susceptibility to type 1 diabetes. Enhanced antibody concentrations to cow milk may provide a biomarker of immune system prone to develop islet autoimmunity. This trial was registered at clinicaltrials.gov as NCT00179777.
TRIGR(NCT00179777)试验发现,水解配方和普通婴儿配方奶粉在降低 1 型糖尿病风险方面没有差异。然而,在前瞻性队列研究中,儿童期摄入牛奶与 1 型糖尿病风险始终相关。
我们的主要目的是研究 TRIGR 儿童的牛奶和牛奶摄入的体液免疫反应是否与 1 型糖尿病相关。
TRIGR 纳入了 2002 年至 2007 年间在 15 个国家出生的 2159 名遗传易患 1 型糖尿病的儿童。儿童被随机分为接受深度水解酪蛋白或普通牛奶配方的两组,并随访至 10 岁。分析了与 1 型糖尿病相关的自身抗体和牛奶蛋白抗体。通过结构化膳食访谈和食物频率问卷测量婴儿配方奶粉的摄入量,通过结构化膳食访谈和食物频率问卷测量牛奶摄入量。使用 Cox 生存模型分析牛奶抗体和牛奶消耗与发展为 1 型糖尿病的风险之间的关联。
脐带血中的牛奶抗体浓度[胰岛自身免疫的危险比(HR):1.30;95%置信区间(CI):1.05,1.61;1 型糖尿病的 HR:1.32;95%CI:1.02,1.71]和从出生到 3 岁的纵向牛奶抗体浓度[胰岛自身免疫的 HR:1.39;95%CI:1.07,1.81;1 型糖尿病的 HR:1.43;95%CI:1.04,1.96]均与发展为 1 型糖尿病的风险增加相关。普通婴儿配方组中,普通婴儿配方的摄入量与胰岛自身免疫风险降低相关(HR:0.92;95%CI:0.85,0.99)。此外,婴儿期后频繁饮用液态奶与胰岛自身免疫或 1 型糖尿病的风险增加相关。
在遗传易患 1 型糖尿病的儿童中,牛奶抗体浓度升高和婴儿期后大量饮用液态奶与 1 型糖尿病的发展有关。对牛奶的抗体浓度升高可能提供了一个易于发生胰岛自身免疫的免疫系统的生物标志物。该试验在 clinicaltrials.gov 上注册为 NCT00179777。